Clinical Trial Update: Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

View source ↗

Summary

This document describes a post-marketing surveillance clinical trial of Alhemo for Hemophilia A and Hemophilia B, sponsored by Novo Nordisk A/S, currently enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ALHEMO (Concizumab)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A, Haemophilia B | Status: ENROLLING_BY_INVITATION